Related Experiment Video

Updated: Jul 16, 2026

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation
07:15

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation

Published on: November 26, 2011

MEK1 activation by PAK: a novel mechanism

Electa R Park1, Scott T Eblen, Andrew D Catling

  • 1Department of Biochemistry, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

Cellular Signalling
|February 23, 2007
PubMed

Insights

p21-activated kinase (PAK) directly activates MEK1, a key component of the Extracellular signal-Regulated Kinase (ERK) pathway. This novel mechanism bypasses conventional Ras/Raf signaling, offering new insights into cancer cell proliferation and migration.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Extracellular signal-Regulated Kinase (ERK) pathway regulates crucial cellular functions like proliferation and motility.
  • While Ras/B-Raf mutations drive ERK activation in some cancers, others show elevated ERK signaling without these mutations.

Purpose of the Study:

  • To investigate a novel mechanism of MEK1 activation by p21-activated kinase (PAK).
  • To elucidate the role of PAK in ERK pathway activation independent of Ras/Raf signaling.

Main Methods:

  • In vitro biochemical assays to assess MEK1 activation by PAK.
  • Site-directed mutagenesis to identify key phosphorylation sites on MEK1.
  • Cell culture experiments using fibroblasts expressing activated PAK1.

Main Results:

  • PAK directly phosphorylates MEK1 at serine 298, stimulating its autophosphorylation and activity towards ERK.
  • MEK1 activation by PAK requires serines 218 and/or 222 in the MEK1 activation loop.
  • This PAK-mediated MEK1 activation mechanism was confirmed in cell culture experiments.

Conclusions:

  • PAK provides a direct activation route for MEK1, distinct from canonical Ras/Raf pathways.
  • This pathway may contribute to aberrant ERK signaling and anchorage-independent growth in tumors lacking Ras/Raf mutations.
  • PAK-mediated MEK1 activation could be a target for cancer therapy, particularly in localized signaling during cell adhesion and migration.

More Related Videos

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...